IT1305303B1 - Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica. - Google Patents

Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.

Info

Publication number
IT1305303B1
IT1305303B1 IT1999RM000151A ITRM990151A IT1305303B1 IT 1305303 B1 IT1305303 B1 IT 1305303B1 IT 1999RM000151 A IT1999RM000151 A IT 1999RM000151A IT RM990151 A ITRM990151 A IT RM990151A IT 1305303 B1 IT1305303 B1 IT 1305303B1
Authority
IT
Italy
Prior art keywords
permeazion
transdermal
promoter
essential oil
niaouli essential
Prior art date
Application number
IT1999RM000151A
Other languages
English (en)
Inventor
Marco Fabrizio Saettone
Boris Giannaccini
Daniela Monti
Enrico Boldrini
Pietro Bianchini
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Priority to IT1999RM000151A priority Critical patent/IT1305303B1/it
Priority to EP00911257A priority patent/EP1159009A2/en
Priority to AU33240/00A priority patent/AU3324000A/en
Priority to PCT/IT2000/000079 priority patent/WO2000053228A2/en
Publication of ITRM990151A1 publication Critical patent/ITRM990151A1/it
Application granted granted Critical
Publication of IT1305303B1 publication Critical patent/IT1305303B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT1999RM000151A 1999-03-10 1999-03-10 Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica. IT1305303B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT1999RM000151A IT1305303B1 (it) 1999-03-10 1999-03-10 Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.
EP00911257A EP1159009A2 (en) 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer
AU33240/00A AU3324000A (en) 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer
PCT/IT2000/000079 WO2000053228A2 (en) 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000151A IT1305303B1 (it) 1999-03-10 1999-03-10 Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.

Publications (2)

Publication Number Publication Date
ITRM990151A1 ITRM990151A1 (it) 2000-09-10
IT1305303B1 true IT1305303B1 (it) 2001-05-04

Family

ID=11406548

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000151A IT1305303B1 (it) 1999-03-10 1999-03-10 Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.

Country Status (4)

Country Link
EP (1) EP1159009A2 (it)
AU (1) AU3324000A (it)
IT (1) IT1305303B1 (it)
WO (1) WO2000053228A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
DE10053383A1 (de) * 2000-10-27 2002-05-08 Bionorica Arzneimittel Gmbh Verwendung von Terpenen als Enhancer der transmucosalen Resorption und Terpene enthaltende pharmazeutische Zubereitungen
DE10056011A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.
US20110105480A1 (en) * 2008-06-24 2011-05-05 Keith Freehauf Pharmaceutical transdermal compositions and method for treating inflammation in cattle
MX2016016469A (es) 2014-06-30 2017-04-10 Koninklijke Philips Nv Portador de muestras para muestras biologicas.
US10232048B1 (en) * 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
ES2963687T3 (es) * 2017-12-11 2024-04-01 Australian Meat & Live Stock Formulación analgésica transdérmica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2783092A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Composition for topical application
DE19518836C2 (de) * 1995-05-23 1997-05-22 Gisela Hartwig Arznei- oder Heilmittel, insbesondere zur Verhütung und Behandlung von Dekubitus
IT1297080B1 (it) * 1997-11-26 1999-08-03 Andrea Carnevali Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee

Also Published As

Publication number Publication date
ITRM990151A1 (it) 2000-09-10
AU3324000A (en) 2000-09-28
WO2000053228A3 (en) 2000-11-16
WO2000053228A2 (en) 2000-09-14
EP1159009A2 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
ATE249206T1 (de) Langwirkende, injizierbare, formulierungen enthaltend rizinusöl
IS6362A (is) Úrea (eða þvagefnis) efnasambönd sem hafa múskarín viðtaka mótlyfs virkni
PT911333E (pt) Derivados de pirazolo¬4,3-d|pirimidina e composicoes farmaceuticas que os contenham
ATE297203T1 (de) Antithrombotische mitteln
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO20013909L (no) Heteroaryl-substituerte kinolin-2-on derivater nyttige som anticancer midler
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
MXPA03001495A (es) Derivados de fenilalanina novedosos.
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
BR0000327B1 (pt) cabeÇa de poÇo.
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
SE9901077D0 (sv) Novel use
PT1009436E (pt) Derivado de acridina para aumentar a biodisponibilidade oral do taxol
IT1305303B1 (it) Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.
EE04059B1 (et) Kloropuriinvaheühendite sünteesimeetod
NO20015330D0 (no) Ny promoter for genekspresjon
IT1297786B1 (it) Pompa dell'olio per compressore
DE10083631T1 (de) Schmiermittelzusammensetzung
IT1320292B1 (it) Struttura di passaggio di alimentazione dell'olio per un albero agomiti
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
IT1307343B1 (it) Attrezzo per il potenziamento dell'attivita' circolatoria
ITFI990059V0 (it) Attrezzo per il potenziamento dell'attivita' circolatoria